Michael L. Moore

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

Thomas D. Meek, Dennis M. Lambert, Geoffrey B. Dreyer et al. · Nature · 1990 · 231 citations

Hiv-1 Protease, Biochemistry, Human Retrovirus +11

Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.

Geoffrey B. Dreyer, Brian W. Metcalf, Thaddeus A. Tomaszek et al. · Proceedings of the National Academy of Sciences · 1989 · 202 citations · Full text

Substrate Analogue Inhibitors, Peptide Analogues, Immunology +17

Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.

Thomas D. Meek, Brian D. Dayton, Brian W. Metcalf et al. · Proceedings of the National Academy of Sciences · 1989 · 176 citations · Full text

Viral Replication, Hiv-1 Protease, Biochemistry +15

Peptide substrates and inhibitors of the HIV-1 protease

Michael L. Moore, William M. Bryan, Stephen A. Fakhoury et al. · Biochemical and Biophysical Research Communications · 1989 · 161 citations

Biochemistry, Protein Folding, Medicine +6

A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site

Mary Ann Hardwicke, Alan R. Rendina, Shawn P. Williams et al. · Nature Chemical Biology · 2014 · 103 citations · Full text

Metabolic Syndrome, Lipid Synthesis, Biochemistry +9